NCT02861157 (OMMS) is a Phase 2 clinical trial of Planet T1D in Diabetes Mellitus, Type 1, sponsored by 3-C Institute for Social Development.

Who is sponsoring NCT02861157?

NCT02861157 is sponsored by 3-C Institute for Social Development.

What drugs are being tested in NCT02861157?

Interventions in NCT02861157: Planet T1D.

What condition does NCT02861157 study?

NCT02861157 studies Diabetes Mellitus, Type 1.

Is NCT02861157 still recruiting?

NCT02861157 is currently completed. Last updated 30 January 2017.

Last reviewed 2017-01-30 · How we verify

NCT02861157: OMMS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mobile Technology & Online Tools to Track Adherence in Chronic Illness Patients

Completed Phase 2 Last updated 30 January 2017

What this trial tests

Phase 2 trial testing Planet T1D in Diabetes Mellitus, Type 1 in 200 participants. Completed in 12 September 2016.

Timeline

1 July 2015

Primary endpoint
12 September 2016

12 September 2016

Quick facts

Lead sponsor	3-C Institute for Social Development
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	200
Start date	1 July 2015
Primary completion	12 September 2016
Estimated completion	12 September 2016
Sites	1 location across United States

Drugs / interventions tested

Planet T1D

Conditions studied

Diabetes Mellitus, Type 1 — all drugs for Diabetes Mellitus, Type 1 →

Sponsor

3-C Institute for Social Development

Who can join

Adults 12 to 17, any sex, with Diabetes Mellitus, Type 1. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this project is to test the efficacy of Planet T1D, a mobile and web-based technology infrastructure specifically designed to (a) enhance youths' type 1 diabetes disease- and treatment-related knowledge through interactive and game-based educational materials; (b) support adherence to the treatment regimen through customized task prompts via mobile and web-based delivery; and (c) promote patient-provider communication through real-world data collection and feedback loops. Investigators will examine the effectiveness of the Planet T1D mobile app and website in improving treatment adherence, disease-related knowledge, transition readiness, condition management, and the psychological correlates of these variables in youth with type 1 diabetes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Trends of Decentralized Clinical Trials Using Digital Technology for Decentralization
Sato T, Mizumoto S, Ota M, Shikano M. · · 2022 · DOI 10.2139/ssrn.4243284

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus, Type 1

Currently open trials in the same condition.

NCT07325461 — Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes · NA · recruiting
NCT07305805 — A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 Diabetes · Phase 1 · recruiting
NCT06282055 — Trajectories in Insulin Sensitivity Across MEnstrual cycleS in Women With Type 1 Diabetes · recruiting
NCT06325202 — Closed Loop and Education for Hypoglycemia Awareness Restoration · NA · recruiting
NCT07160816 — A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar · recruiting

Other 3-C Institute for Social Development trials

Trials by the same sponsor.

NCT07300930 — A Mobile Text Approach to Measurement and Feedback for Wraparound Care Coordination · NA · not yet recruiting
NCT06728800 — Leveraging Interactive Digital Technology to Increase Access to Family-Based Behavioral Treatment for Childhood Obesity · NA · not yet recruiting
NCT06728683 — Assist MH Digital Technologies to Support School Mental Health Care · NA · completed
NCT06213142 — Developing the Unified Protocol-Single Session Experience Platform for Adolescent Mental Health · NA · completed
NCT05743712 — Pilot Test of a Mobile Text Approach to Measurement and Feedback for Wraparound Care Coordination · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02861157 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by 3-C Institute for Social Development
Last refreshed: 30 January 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02861157.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing